Clinical Trials Directory

Trials / Completed

CompletedNCT00669682

T-wave Alternans and Intrathoracic Impedance Measurements

Status
Completed
Phase
Study type
Observational
Enrollment
9 (actual)
Sponsor
Columbia University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

T-wave alternans is a test that is currently being used to risk stratify patients with structural heart disease for sudden cardiac death. The mechanism of T-wave alternans is unclear, but may share a common abnormality with conditions of cardiac fluid overload such as heart failure, which is altered intracellular calcium handling. Current Medtronic implantable defibrillators have the capability of monitoring cardiac fluid status via transthoracic impedance measurements. The purpose of this study is to determine if a correlation exists between T-wave alternans status and cardiac volume status, as determined by transthoracic impedance measurements. Secondarily, the study seeks to examine the relationship between arrhythmia frequency and T-wave alternans or cardiac volume status.

Conditions

Interventions

TypeNameDescription
OTHERCongestive heart failureSpontaneous occurrence of fluid overload.

Timeline

Start date
2008-08-01
Primary completion
2012-04-01
Completion
2012-04-01
First posted
2008-04-30
Last updated
2013-04-19
Results posted
2013-03-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00669682. Inclusion in this directory is not an endorsement.

T-wave Alternans and Intrathoracic Impedance Measurements (NCT00669682) · Clinical Trials Directory